Skip to main content
. 2022 May 21;67:116838. doi: 10.1016/j.bmc.2022.116838

Fig. 4.

Fig. 4

Binding curves of 9a and 9r with human ACE2 and SARS-CoV-2 spike RBD proteins by BLI binding kinetics assay. (A) and (B): Compounds 9a and 9r binding to SARS-CoV-2 spike RBD protein, respectively; (C) and (D): The interaction of 9a and 9r binding to human ACE2 protein, respectively.